Company profile
CytoLynx Therapeutics company profile
CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Shaxi, Fujian, China
- Country code
- CN
- Continent
- Asia